Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000401:mortality / Q000473:pathology; D000293:Adolescent; D000328:Adult; D000818:Animals; D001798:Blood Proteins / Q000032:analysis; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000378:metabolism / Q000652:urine; D002278:Carcinoma in Situ / Q000139:chemically induced; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004054:Diethylstilbestrol / Q000009:adverse effects / Q000627:therapeutic use; D004967:Estrogens / Q000009:adverse effects / Q000652:urine; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011374:Progesterone / Q000009:adverse effects; D013739:Testosterone / Q000096:biosynthesis; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced*; D014594:Uterine Neoplasms / Q000139:chemically induced*; D014623:Vaginal Diseases / Q000139:chemically induced; D014625:Vaginal Neoplasms / Q000139:chemically induced* / Q000401:mortality / Q000473:pathology; D014626:Vaginal Smears
D001798:Blood Proteins; D003276:Contraceptives, Oral; D004967:Estrogens; D013739:Testosterone; D011374:Progesterone; D004054:Diethylstilbestrol